Monitoring the impact of regulatory measures on medicine pricing in Thailand: an observation over a 16-year span
The strategic interventions implemented by the Thai government have markedly enhanced the regulation and affordability of medicine prices. However, to sustain these achievements and ensure the viability of the local pharmaceutical industry, ongoing efforts and policy adaptations are essential. This study emphasises the critical need for continuous evaluation of these policies to respond effectively to evolving healthcare and economic conditions.
Authors
- Zaheer‐Ud‐Din Babar (ORCID: https://orcid.org/0000-0003-1051-3240)
- Siriwat Suwattanapreeda
- Kusawadee Maluangnon (ORCID: https://orcid.org/0000-0001-9875-561X)
- Sanita Hirunrassamee (ORCID: https://orcid.org/0009-0002-4165-3123)
- Chaoncin Sooksriwong (ORCID: https://orcid.org/0000-0002-6188-882X)
- Thirapich Chuachantra
- Krissana Kuchaisit
- Niti Osirisakul
Institutions
- Thammasat University (TH)
- Ministry of Public Health (TH)
- Ramathibodi Hospital (TH)
- Somdet Chaopraya Institute of Psychiatry (TH)
- Food and Drug Administration (TH)
- Qatar University (QA)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1080/20523211.2025.2465801
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Health Systems Research Institute